FormWeb • telmisartan-hydroCHLOROthiazide

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

telmisartan-hydroCHLOROthiazide

telmisartan-hydroCHLOROthiazide

Restricted ARB Combination Products Formulary
Restricted Micardis HCT --> Restricted to NO SUB orders.
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Micardis HCT	TABLET, ORAL	40 mg-12.5 mg, 80 mg-12.5 mg, 80 mg-25 mg

VIEW MORE Angiotensin II Receptor Antagonists, Thiazide Diuretics

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

telmisartan-hydroCHLOROthiazide (Micardis HCT)

40 mg-12.5 mg po tablet Daily

losartan-hydroCHLOROthiazide (Hyzaar)

100 mg-12.5 mg po tablet Daily

telmisartan-hydroCHLOROthiazide (Micardis HCT)

80 mg-12.5 mg po tablet Daily
80 mg-25 mg po tablet Daily

valsartan-hydroCHLOROthiazide (Diovan HCT)

320 mg-12.5 mg po tablet Daily
TWO 160 mg-12.5 mg po tablets Daily (Total: 320 mg-25 mg)

Reviewed: April 27, 2010.

Last updated: Dec. 26, 2017

Black Box Warning: Telmisartan: pregnancy risk

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.